Newark Charter student’s work leads to gene editing breakthrough at ChristianaCare

If you, or someone you love, has ever been diagnosed with cancer, you know how scary it can be thinking about the treatment that lies ahead.

Researchers at the Gene Editing Institute within the Helen F. Graham Cancer Research Center at ChristianaCare Health System on Ogletown-Stanton Road also know. What they know — and now they want the public to know as well — is that the research being conducted on the ChristianaCare campus is making great strides in cancer treatment research using DECODR.

First of all, DECODR is an abbreviation for “Deconvolution of Complex DNA Repair.” It’s a computer system that was developed and licensed at ChristianaCare; however, it’s now in use all over the country, according to Pawel Bialk, associate director of technology development at the Gene Editing Institute and chief technology officer at DECODR…

Story continues

TRENDING NOW

LATEST LOCAL NEWS